THE 62-KDA AND 80-KDA SUBUNITS OF TRANSCRIPTION FACTOR IIH MEDIATE THE INTERACTION WITH EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN-2

被引:94
作者
TONG, X
DRAPKIN, R
REINBERG, D
KIEFF, E
机构
[1] HARVARD UNIV,SCH MED,DEPT MED & MICROBIOL & MOLEC GENET,BOSTON,MA 02115
[2] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,HOWARD HUGHES MED INST,DEPT BIOCHEM,PISCATAWAY,NJ 08854
关键词
D O I
10.1073/pnas.92.8.3259
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
EBNA 2 (Epstein-Barr virus nuclear antigen 2) is an acidic transactivator essential for EBV transformation of B lymphocytes. We show that EBNA 2 directly interacts with general transcription factor IIH. Glutathione S-transferase (GST)-EBNA 2 acidic domain fusion protein depleted transcription factor IIH activity from a TFIIH nuclear fraction. The p89 (ERCC3), p80 (ERCC2), and p62 sub-units of TFIIH were among the proteins retained by GST-EBNA 2. Eluates from the GST-EBNA 2 beads reconstituted activity in a TFIIH-dependent in vitro transcription assay. The p62 and p80 subunits of TFIIH independently bound to GST-EBNA 2, whereas the p34 subunit of TFIIH only bound in the presence of p62. A Trp --> Thr mutation in the EBNA 2 acidic domain abolishes EBNA 2 transactivation in vivo and greatly compromised EBNA 2 association with TFIIH activity and with the p62 and p80 subunits, providing a link between EBNA 2 transactivation and these interactions. Antibodies directed against the p62 subunit of TFIIH coimmunoprecipitated EBNA 2 from EBV-transformed B lymphocytes, indicating that EBNA 2 associates with TFIIH in vivo.
引用
收藏
页码:3259 / 3263
页数:5
相关论文
共 50 条
[1]  
Cohen J.I., Wang F., Mannick J., Kieff E., Proc. Natl. Acad. Sci. USA, 86, pp. 9558-9562, (1989)
[2]  
Hammerschmidt W., Sugden B., Nature (London), 340, pp. 393-397, (1989)
[3]  
Abbot S.D., Rowe M., Cadwallader K., Ricksten A., Gordon J., Wang F., Rymo L., Rickinson A.B., J. Virol., 64, pp. 2126-2134, (1990)
[4]  
Wang F., Tsang S.F., Kurilla M.G., Cohen J.I., Kieff E., J. Virol., 64, pp. 3407-3416, (1990)
[5]  
Cordier M., Calender A., Billaud M., Zimber U., Rousselet G., Pavlish O., Banchereau J., Tursz T., Bornkamm G., Lenoir G.M., J. Virol., 64, pp. 1002-1013, (1990)
[6]  
Wang F., Gregory C.D., Rowe M., Rickinson A.B., Wang D., Birkenbach M., Kikutani H., Kishimoto T., Kieff E., Proc. Natl. Acad. Sci. USA, 84, pp. 3452-3456, (1987)
[7]  
Wang F., Gregory C., Sample C., Rowe M., Liebowitz D., Murray R., Rickinson A., Kieff E., J. Virol., 64, pp. 2309-2318, (1990)
[8]  
Wang F., Kikutani H., Tsang S.F., Kishimoto T., Keiff E., J. Virol., 65, pp. 4101-4106, (1991)
[9]  
Knutson J.C., J. Virol., 64, pp. 2530-2536, (1990)
[10]  
Fahraeus R., Jansson A., Sjoblom A., Nilsson T., Klein G., Rymo L., Virology, 195, pp. 71-80, (1993)